Type 1 leprosy reversal reaction treated with topical tacrolimus along with systemic corticosteroids.
Indian J Med Sci
;
2009 Aug; 63(8) 359-362
Artigo
em Inglês
| IMSEAR
| ID: sea-145434
ABSTRACT
An 11-year-old black Haitian boy presented with borderline lepromatous leprosy and was treated with rifampicin, dapsone, and clofazimine. After 4 months he developed a severe type 1 reversal reaction without nerve involvement. He was started on prednisolone (1 mg/kg daily). After 4 weeks of treatment with corticosteroids, his condition did not improve and the lesions remained painful. The patient was given a therapeutic trial with twice daily application of topical tacrolimus 0.1% ointment. The result was a dramatic improvement in the skin lesions. The patient's condition was maintained by topical tacrolimus therapy, with healing of all skin lesions. The prednisolone dose was then tapered to zero over a period of 12 weeks. To the best of our knowledge, this is the first report of the efficacy of topical tacrolimus in the treatment of type 1 leprosy reaction.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Humanos
/
Masculino
/
Prednisolona
/
Hanseníase Dimorfa
/
Criança
/
Administração Tópica
/
Tacrolimo
/
Quimioterapia Combinada
/
Glucocorticoides
/
Haiti
País/Região como assunto:
Caribe
/
Haiti
Idioma:
Inglês
Revista:
Indian J Med Sci
Ano de publicação:
2009
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS